Search

everythinglearnresearchcommunity

for

Search:↓

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Married women with type 2 diabetes had a surprisingly low infertility rate, suggesting type 2 diabetes and PCOS may be different conditions.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Metabolic syndrome reduces effectiveness of hair loss treatment.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Pregnancy can trigger follicular mucinosis, which may resolve after delivery.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

NX35growth™ effectively promotes hair growth and improves hair health.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Darier-White disease causes skin and nail issues, starts around age 20, worsens until 40-50, and has poor treatment options.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

Most Cochrane Skin Group reviews are helpful for improving dermatology practices, but some lack enough evidence for clinical recommendations.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Pregnancy can cause skin changes and may affect pre-existing skin conditions, with some treatments not safe for use during pregnancy.

Videodermoscopy better identifies female hair loss than clinical diagnosis.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Pregnancy can cause normal skin changes that usually go away after childbirth and don't need treatment.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Most skin changes during pregnancy are harmless and moles don't significantly change, but many women experience pigmentation changes due to hormones and sun exposure.